Between 2000 and 2020, Medtronic filed 16845 patent applications at the USPTO and abandoned 2290 (13.59%) patent applications.
A disease can remain undetected even when a patient has already undergone medical testing. The challenge is often recognizing the warning signs hidden within routine clinical data. For example, a…
A patent-led view of where GLP-2 innovation is moving – from peptide and biologic protection toward longer-acting therapies, formulations, dosing, manufacturing, oral delivery, and multi-receptor strategies. GLP-2 Is Entering a…
Viatris has a total of 3371 patents globally, out of which 1550 have been granted. Of these 3371 patents, 22.15% patents are active. India is where Viatris has filed the…
